Drug-induced Pisa syndrome (pleurothotonus): Epidemiology and management

CNS Drugs

Volumn 16, Issue 3, 2002, Pages 165-174

  Suzuki, Toshihito ^a   Matsuzaka, Hisashi ^b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Mitsukaido Kosei Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZATROPINE; BUTYROPHENONE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PHENOTHIAZINE DERIVATIVE; SERTINDOLE; TIAPRIDE; TRIHEXYPHENIDYL;

BRAIN FUNCTION; CHOLINERGIC SYSTEM; CLINICAL FEATURE; DELUSION; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DYSTONIA; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; NEUROTRANSMISSION; NORADRENERGIC SYSTEM; ONSET AGE; PATHOPHYSIOLOGY; PISA SYNDROME; PLEUROTHOTONUS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; SYMPTOM; TARDIVE DYSKINESIA;

EID: 0036214592     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200216030-00003     Document Type: Review

References (74)

1. A survey of drug-induced extrapyramidal reactions
2. Drug-induced dystonia tarda: Treatment with L-dopa
3. Practical management of dystonia
4. Tardive dystonia: Late-onset and persistent dystonia caused by antipsychotic drugs
5. Neuroleptic-associated tardive syndromes
6. New dystonic syndrome associated with butyrophenone therapy
7. The Pisa syndrome: A report of two cases
8. Tardive dystonia and Pisa syndrome
9. The Pisa syndrome during maintenance antipsychotic therapy
10. Pisa syndrome, or pleurothotonus
11. Pisa syndrome: Report of a case
12. Pisa syndrome in Alzheimer's disease
13. The Pisa syndrome: Possible role for serotonin and noradrenaline
14. Pisa syndrome in a Chinese patient
15. Clinical characteristics of the Pisa syndrome
16. Pisa syndrome in an adolescent on neuroleptic medication
17. Use of pimozide in the Pisa syndrome
18. Pisa syndrome mistaken for conversion in an adolescent
19. Pisa-syndrom
20. Pisa-syndrome unter clozapintherapie
21. The Pisa syndrome (pleurothotonus) during antidepressant therapy
22. The Pisa syndrome as another acute dystonia subtype
23. Pisa syndrome during treatment with sertindole
24. Metronome or alternating Pisa syndrome: A form of tardive dystonia under clozapine treatment
25. Effectiveness of anticholinergics and neuroleptic dose reduction on neuroleptic-induced pleurothotonus (the Pisa syndrome)
26. Relation between cholinesterase inhibitor and Pisa syndrome
27. Primary anticholinergic-responsive Pisa syndrome
28. Pisa syndrome due to a cholinesterase inhibitor (donepezil): A case report
29. The Pisa syndrome (or pleurothotonus): Prevalence in a psychogeriatric population
30. Pisa syndrome (pleurothotonus): Report of a multicenter drug safety surveillance project
31. Pisa syndrome without neuroleptic exposure in a patient with dementia of the Alzheimer type
32. Pisa syndrome in a patient with multiple system atrophy
33. Clinical features and natural history of axial predominant adult onset primary dystonia
34. Pleurothotonus and the Pisa syndrome
35. Pisa syndrome - A confusing term
36. Tardive dystonia: Treatment with trihexyphenidyl
37. Pharmacologic studies of tardive dyskinesia
38. A review of 32 cases of tardive dystonia
39. Tardive dystonia. Prevalence, risk factors, and comparison with tardive dyskinesia in a population of 200 acute psychiatric inpatients
40. Tardive dystonia and severe tardive dyskinesia
41. Fluoxetine and extrapyramidal side effects
42. Fluoxetine and extrapyramidal side effects
43. Natural history and treatment of tardive dystonia
44. Clinical forms of severe tardive dyskinesia
45. Factors in the development of severe forms of tardive dyskinesia
46. Drug treatment of hyperkinetic movement disorders
47. High-dose bromocriptine in a case of tardive dystonia
48. Clozapine and tardive dystonia
49. The effects of clozapine on tardive dyskinesia
50. High dosage anticholinergic therapy in dystonia
51. Tardive dystonia: Four cases histories
52. Tardive dyskinesia in elderly psychiatric patients in Singapore
53. Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong
54. Dystonic reactions following neuroleptics: Time course and proposed mechanisms
55. Antidepressant treatment and side effect considerations
56. Biological basis of depression and therapeutic relevance
57. Effects of serotonergic and anticholinergic drugs in haloperidol-induced dystonia in Cebus monkeys
58. The role of serotonin in schizophrenia
59. Extrapyramidal symptoms with selective serotonin reuptake inhibitors
60. Dopaminergic and serotonergic aspects of acute extrapyramidal syndromes
61. Tardive dystonia in a psychiatric hospital
62. Pharmacologic implications of hemispheric asymmetry
63. Lateralization of norepinephrine in human thalamus
64. Lateral asymmetry of neurotransmitters in human brain
65. Left hemisphere hyperactivity in schizophrenia: Abnormality inherent to psychosis or neuroleptic side-effects?
66. Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia
67. No D2 receptor increase in PET study of schizophrenia
68. Serotonergic interhemispheric asymmetry: Gender difference in the orbital cortex
69. Curvature of the spine in post-encephalitic parkinsonism
70. Note on the scoliosis of parkinsonism
71. Central dopaminergic pathways in hemiparkinsonism examined by positron emission tomography
72. Pure hemidystonia with basal ganglion abnormalities on positron emission tomography
73. Hemiparkinsonism: A human model for studying dopaminergic supersensitivity